WANG, JIAN MIN
WANG, JIAN MIN
Fisica e Astronomia
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial
2024 Harrison, Claire N; Mesa, Ruben; Talpaz, Moshe; Al-Ali, Haifa Kathrin; Xicoy, Blanca; Passamonti, Francesco; Palandri, Francesca; Benevolo, Giulia; Vannucchi, Alessandro Maria; Mediavilla, Clemence; Iurlo, Alessandra; Kim, InHo; Rose, Shelonitda; Brown, Patrick; Hernandez, Christopher; Wang, Jia; Kiladjian, Jean-Jacques
Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial
2024 Gupta, Vikas; Yacoub, Abdulraheem; Mesa, Ruben A.; Harrison, Claire N.; Vannucchi, Alessandro M.; Kiladjian, Jean-Jacques; Deeg, Hans-Joachim; Fazal, Salman; Foltz, Lynda; Mattison, Ryan J.; Miller, Carole B.; Parameswaran, Vinod; Brown, Patrick; Hernandez, Christopher; Wang, Jia; Talpaz, Moshe
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial | 2024 | Harrison, Claire N; Mesa, Ruben; Talpaz, Moshe; Al-Ali, Haifa Kathrin; Xicoy, Blanca; Passamonti, Francesco; Palandri, Francesca; Benevolo, Giulia; Vannucchi, Alessandro Maria; Mediavilla, Clemence; Iurlo, Alessandra; Kim, InHo; Rose, Shelonitda; Brown, Patrick; Hernandez, Christopher; Wang, Jia; Kiladjian, Jean-Jacques | |
Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial | 2024 | Gupta, Vikas; Yacoub, Abdulraheem; Mesa, Ruben A.; Harrison, Claire N.; Vannucchi, Alessandro M.; Kiladjian, Jean-Jacques; Deeg, Hans-Joachim; Fazal, Salman; Foltz, Lynda; Mattison, Ryan J.; Miller, Carole B.; Parameswaran, Vinod; Brown, Patrick; Hernandez, Christopher; Wang, Jia; Talpaz, Moshe |